Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6385) 6385
Book Review (766) 766
Publication (365) 365
Newsletter (267) 267
Conference Proceeding (44) 44
Magazine Article (32) 32
Book Chapter (22) 22
Newspaper Article (21) 21
Dissertation (16) 16
Trade Publication Article (7) 7
Book / eBook (2) 2
Paper (2) 2
Web Resource (2) 2
Data Set (1) 1
Government Document (1) 1
Reference (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
sertraline (4589) 4589
index medicus (4138) 4138
humans (4011) 4011
psychiatry (2626) 2626
male (2565) 2565
female (2535) 2535
adult (1901) 1901
middle aged (1489) 1489
serotonin uptake inhibitors - therapeutic use (1451) 1451
sertraline - therapeutic use (1424) 1424
pharmacology & pharmacy (1408) 1408
fluoxetine (1324) 1324
treatment outcome (1211) 1211
antidepressants (1191) 1191
depression (1157) 1157
antidepressive agents - therapeutic use (1024) 1024
double-blind (1018) 1018
aged (893) 893
paroxetine (851) 851
serotonin uptake inhibitors - adverse effects (768) 768
depressive disorder - drug therapy (767) 767
neurosciences (740) 740
drug therapy (727) 727
clinical neurology (698) 698
major depression (694) 694
double-blind method (691) 691
adolescent (662) 662
sertraline - adverse effects (608) 608
depressive disorder, major - drug therapy (572) 572
1-naphthylamine - analogs & derivatives (570) 570
serotonin reuptake inhibitors (570) 570
efficacy (545) 545
animals (535) 535
depression, mental (533) 533
serotonin (515) 515
psychiatric status rating scales (503) 503
psychology, clinical (489) 489
placebo (455) 455
research (455) 455
serotonin uptake inhibitors - pharmacology (443) 443
dose-response relationship, drug (425) 425
care and treatment (424) 424
antidepressive agents - adverse effects (423) 423
abridged index medicus (420) 420
serotonin uptake inhibitors (407) 407
depression - drug therapy (406) 406
sertraline - pharmacology (394) 394
mental depression (384) 384
citalopram (379) 379
fluvoxamine (377) 377
analysis (360) 360
serotonin uptake inhibitors - administration & dosage (358) 358
sertraline - administration & dosage (358) 358
major depressive disorder (354) 354
comorbidity (351) 351
clinical trials (341) 341
child (321) 321
fluoxetine - therapeutic use (319) 319
anxiety (317) 317
medicine, general & internal (314) 314
antidepressant (311) 311
rats (308) 308
drug therapy, combination (303) 303
drugs (303) 303
1-naphthylamine - therapeutic use (290) 290
dosage and administration (287) 287
severity of illness index (287) 287
placebo-controlled trial (286) 286
symptoms (286) 286
obsessive-compulsive disorder (281) 281
depressive disorder - psychology (278) 278
health aspects (277) 277
risk factors (276) 276
paroxetine - therapeutic use (272) 272
pharmacotherapy (270) 270
drug interactions (268) 268
article (267) 267
drug administration schedule (267) 267
ptsd (257) 257
venlafaxine (257) 257
young adult (257) 257
antidepressive agents, second-generation - therapeutic use (256) 256
medicine & public health (256) 256
children (255) 255
time factors (253) 253
imipramine (251) 251
disorder (250) 250
psychology (250) 250
cognitive therapy (236) 236
ssris (236) 236
combined modality therapy (233) 233
ssri (230) 230
prevalence (222) 222
metaanalysis (221) 221
citalopram - therapeutic use (220) 220
antidepressive agents - pharmacology (217) 217
follow-up studies (217) 217
aged, 80 and over (214) 214
obsessive-compulsive disorder - drug therapy (213) 213
psychotherapy (212) 212
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6406) 6406
German (70) 70
Spanish (64) 64
French (50) 50
Turkish (41) 41
Russian (31) 31
Portuguese (22) 22
Japanese (21) 21
Chinese (17) 17
Polish (9) 9
Czech (8) 8
Italian (7) 7
Danish (5) 5
Dutch (4) 4
Swedish (4) 4
Hungarian (3) 3
Norwegian (3) 3
Persian (2) 2
Serbian (2) 2
Croatian (1) 1
Hebrew (1) 1
Korean (1) 1
Romanian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Sertraline versus placebo in patients with major depressive disorder undergoing hemodialysis: A randomized, controlled feasibility trial
by Friedli, Karin and Guirguis, Ayman and Almond, Michael and Day, Clara and Chilcot, Joseph and Da Silva-Gane, Maria and Davenport, Andrew and Fineberg, Naomi A and Spencer, Benjamin and Wellsted, David and Farrington, Ken
Clinical Journal of the American Society of Nephrology, ISSN 1555-9041, 2017, Volume 12, Issue 2, pp. 280 - 286
Background and objectives Depression is common in patients on hemodialysis, but data on the benefits and risks of antidepressants in this setting are limited.... 
Personality inventory | Hemodialysis | Humans | Feasibility studies | Depression | Depressive disorder, major | Psychiatric status rating scales | Sertraline | Antidepressive agents | Follow-up studies | Double-blind method | Risk assessment | Placebos | Renal dialysis | Controlled clinical trials, randomized | DIAGNOSIS | EFFICACY | UROLOGY & NEPHROLOGY | SYMPTOMS | QUALITY-OF-LIFE | PREVALENCE | CHRONIC KIDNEY-DISEASE | FLUOXETINE | FAILURE | STAGE RENAL-DISEASE | DIALYSIS | Renal Dialysis - psychology | Double-Blind Method | Middle Aged | Renal Insufficiency, Chronic - psychology | Male | Treatment Outcome | Sertraline - adverse effects | Patient Dropouts | Feasibility Studies | Antidepressive Agents - therapeutic use | Renal Insufficiency, Chronic - therapy | Medication Adherence | Psychiatric Status Rating Scales | Sertraline - therapeutic use | Adult | Female | Aged | Antidepressive Agents - adverse effects | Depressive Disorder, Major - diagnosis | Depressive Disorder, Major - drug therapy | Index Medicus | Follow-Up Studies | Risk Assessment | Controlled Clinical Trials, Randomized | Antidepressive Agents | Personality Inventory | hemodialysis | Depressive Disorder, Major | depression | Original | renal dialysis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Determination of select antidepressants in fish from an effluent-dominated stream
by Brooks, Bryan W and Chambliss, C. Kevin and Stanley, Jacob K and Ramirez, Alejandro and Banks, Kenneth E and Johnson, Robert D and Lewis, Russell J
Environmental Toxicology and Chemistry, ISSN 0730-7268, 02/2005, Volume 24, Issue 2, pp. 464 - 469
Increasing evidence indicates widespread occurrence of pharmaceuticals and personal care products (PPCPs) in municipal effluent discharges and surface waters.... 
Fluoxetine | Sertraline | Environmental pharmaceuticals | Municipal effluent | CONTAMINANTS | PUFFER FISH | PHARMACEUTICALS | environmental pharmaceuticals | AQUATIC ENVIRONMENT | RECEPTOR | municipal effluent | SEWAGE | ENVIRONMENTAL SCIENCES | fluoxetine | PHARMACOKINETICS | CLONING | TOXICOLOGY | sertraline | Serotonin Uptake Inhibitors - metabolism | Antidepressive Agents - blood | Antidepressive Agents - analysis | Liver - metabolism | Sertraline - blood | Rivers | Water Pollutants, Chemical - analysis | Fluoxetine - blood | Antidepressive Agents - toxicity | Brain - metabolism | Sertraline - analogs & derivatives | Animals | Water Pollutants, Chemical - toxicity | Time Factors | Fishes | Fluoxetine - analogs & derivatives | Fluoxetine - metabolism | Serotonin Uptake Inhibitors - blood | Muscles - metabolism | Sertraline - metabolism | Creeks & streams | Fish | Antidepressants | Effluents | Aquatic ecosystems | Pharmaceuticals | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Sertraline Treatment of Major Depression in Patients With Acute MI or Unstable Angina
by Glassman, Alexander H and O'Connor, Christopher M and Califf, Robert M and Swedberg, Karl and Schwartz, Peter and Bigger, Jr, J. Thomas and Krishnan, K. Ranga Rama and van Zyl, Louis T and Swenson, J. Robert and Finkel, Mitchell S and Landau, Charles and Shapiro, Peter A and Pepine, Carl J and Mardekian, Jack and Harrison, Wilma M and for the Sertraline Antidepressant Heart Attack Randomized Trial (SADHART) Group and SADHART Grp and Sertraline Antidepressant Heart Attack Randomized Trial (SADHEART) Group and Hjärt-kärlinstitutionen and Sahlgrenska akademin and Göteborgs universitet and Gothenburg University and Cardiovascular Institute and Sahlgrenska Academy
JAMA, ISSN 0098-7484, 08/2002, Volume 288, Issue 6, pp. 701 - 709
CONTEXT Major depressive disorder (MDD) occurs in 15% to 23% of patients with acute coronary syndromes and constitutes an independent risk factor for morbidity... 
MORTALITY | TRIAL | SEROTONIN REUPTAKE INHIBITORS | MEDICINE, GENERAL & INTERNAL | EFFICACY | PROGNOSIS | ACUTE MYOCARDIAL-INFARCTION | DOUBLE-BLIND | RISK | SYMPTOMS | CORONARY-HEART-DISEASE | Depressive Disorder, Major - etiology | Double-Blind Method | Myocardial Infarction - psychology | Humans | Middle Aged | Serotonin Uptake Inhibitors - therapeutic use | Serotonin Uptake Inhibitors - adverse effects | Male | Treatment Outcome | Hospitalization | Sertraline - adverse effects | Angina, Unstable - psychology | Sertraline - therapeutic use | Female | Depressive Disorder, Major - drug therapy | Psychological aspects | Evaluation | Drug therapy | Sertraline | Depression, Mental | Cardiac patients | Clinical trials | Cardiovascular disease | Mental depression | Angina pectoris | Antidepressants | Index Medicus | Abridged Index Medicus | Sertraline/adverse effects/therapeutic use | Serotonin Uptake Inhibitors/adverse effects/therapeutic use | Depressive Disorder | Angina | Unstable/psychology | Kardiologi | Cardiac and Cardiovascular Systems | Myocardial Infarction/psychology | Major/drug therapy/etiology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Serum concentrations of sertraline and N-desmethyl sertraline in relation to CYP2C19 genotype in psychiatric patients
by Rudberg, I and Hermann, M and Refsum, H and Molden, E
European Journal of Clinical Pharmacology, ISSN 0031-6970, 12/2008, Volume 64, Issue 12, pp. 1181 - 1188
To investigate the impact of CYP2C19 genotype on serum concentrations of sertraline and N-desmethyl sertraline in psychiatric patients.Patients treated with... 
Biomedicine | CYP2C1917 | Genotype | N-desmethyl sertraline | Pharmacology/Toxicology | CYP2C19 | Sertraline | GENETIC-POLYMORPHISM | PROTON PUMP INHIBITORS | MAJOR DEPRESSION | IN-VITRO | ANTIDEPRESSANTS | PHARMACOKINETICS | CYP2C19-ASTERISK-17 ALLELE | DEMETHYLATION | MEPHENYTOIN OXIDATION POLYMORPHISMS | PHARMACOLOGY & PHARMACY | DRUG-METABOLISM | Antidepressive Agents - blood | Mental Disorders - blood | Humans | Middle Aged | Aryl Hydrocarbon Hydroxylases - genetics | Sertraline - blood | Male | Chromatography, High Pressure Liquid | Antidepressive Agents - therapeutic use | Genetic Variation | Mental Disorders - genetics | Tandem Mass Spectrometry | Sertraline - analogs & derivatives | Sertraline - pharmacokinetics | Metabolic Clearance Rate - genetics | Cytochrome P-450 CYP2C19 | Mental Disorders - drug therapy | Sertraline - therapeutic use | Adult | Female | Antidepressive Agents - pharmacokinetics | Physiological aspects | Psychiatric patients | Genetic aspects | Analysis | Cytochrome P-450 | Prescription drugs | Genotype & phenotype | Pharmacology | Mental depression | Metabolism | Antidepressants | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Synthesis of polysubstituted olefins by Pd-catalyzed cross-coupling reaction of tosylhydrazones and aryl nonaflates
by Barluenga, José and Florentino, Lucía and Aznar, Fernando and Valdés, Carlos
Organic Letters, ISSN 1523-7060, 02/2011, Volume 13, Issue 3, pp. 510 - 513
Aryl nonaflates are employed as electrophiles in the Pd-catalyzed cross-coupling with tosylhydrazones affording di-, tri-, and tetrasubstituted olefins. Fine... 
HALIDES | CHEMISTRY, ORGANIC | METAL | SERTRALINE | TOSYLATES
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Dysregulated relationship of inflammation and oxidative stress in major depression
by Rawdin, B.J and Mellon, S.H and Dhabhar, F.S and Epel, E.S and Puterman, E and Su, Y and Burke, H.M and Reus, V.I and Rosser, R and Hamilton, S.P and Nelson, J.C and Wolkowitz, O.M
Brain, Behavior, and Immunity, ISSN 0889-1591, 2012, Volume 31, pp. 143 - 152
Highlight â–º The relationship of inflammation to oxidation may be disturbed in untreated major depression; this may reflect or contribute to increased risk of... 
Psychiatry | Allergy and Immunology | Oxidative stress | F2-isoprostane | Depression | Inflammation | Oxidation | Sertraline | IL-6 | IL-10 | METABOLIC SYNDROME | ALZHEIMERS-DISEASE | DNA-DAMAGE | IMMUNOLOGY | NEUROSCIENCES | PROBING INTERACTIONS | INTERFERON-ALPHA | CLINICAL DEPRESSION | CARDIOVASCULAR-DISEASE | TNF-ALPHA | ANTIOXIDATIVE SYSTEMS | MEDIATED IMMUNE ACTIVATION | Sertraline - pharmacology | Depressive Disorder, Major - metabolism | Humans | Middle Aged | Oxidative Stress - physiology | Interleukin-10 - blood | Male | Treatment Outcome | Antidepressive Agents - therapeutic use | Inflammation - metabolism | Interleukin-6 - blood | Sertraline - therapeutic use | Adult | Female | Antidepressive Agents - pharmacology | Oxidative Stress - drug effects | Depressive Disorder, Major - drug therapy | Major depressive disorder | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text A randomized, double-blind, placebo-controlled trial of low-dose sertraline in young children with fragile X syndrome
by Greiss Hess, Laura and Fitzpatrick, Sarah E and Nguyen, Danh V and Chen, Yanjun and Gaul, Kimberly N and Schneider, Andrea and Lemons Chitwood, Kerrie and Eldeeb, Marwa Abd Al Azaim and Polussa, Jonathan and Hessl, David and Rivera, Susan and Hagerman, Randi J
Journal of Developmental and Behavioral Pediatrics, ISSN 0196-206X, 10/2016, Volume 37, Issue 8, pp. 619 - 628
Objective: Observational studies and anecdotal reports suggest that sertraline, a selective serotonin reuptake inhibitor, may improve language development in... 
SSRI | treatment | ASD | Index terms: fragile X syndrome | autism | sertraline | PSYCHOLOGY, DEVELOPMENTAL | fragile X syndrome | PHENOTYPE | MECHANISMS | SYNAPTIC PLASTICITY | SEROTONIN SYNTHESIS | GENE | MOUSE MODEL | INFANTS | DOPAMINE | BEHAVIORAL SCIENCES | PEDIATRICS | SPECTRUM | Outcome Assessment (Health Care) - methods | Sertraline - pharmacology | Double-Blind Method | Humans | Child, Preschool | Serotonin Uptake Inhibitors - adverse effects | Male | Sertraline - adverse effects | Fragile X Syndrome - drug therapy | Sertraline - administration & dosage | Serotonin Uptake Inhibitors - administration & dosage | Female | Serotonin Uptake Inhibitors - pharmacology | Child | Clinical trials | Pediatrics | Genetic disorders | Antidepressants | Placebo effect | Children & youth | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Sertraline hydro-chloride form II
by Ravikumar, K and Sridhar, B and Bhanu, M.N
Acta Crystallographica Section E, ISSN 1600-5368, 02/2006, Volume 62, Issue 2, p. o565
A second polymorph of sertraline hydro-chloride {systematic name: [(1S-cis)-4-(3,4-dichloro-phen-yl)-1,2,3,4-tetra-hydro-1-naphthy]methyl-ammonium chloride}, a... 
Sertraline
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Sertraline in pregnancy – Therapeutic drug monitoring in maternal blood, amniotic fluid and cord blood
by Paulzen, Michael and Goecke, Tamme W and Stickeler, Elmar and Gründer, Gerhard and Schoretsanitis, Georgios
Journal of Affective Disorders, ISSN 0165-0327, 2017, Volume 212, pp. 1 - 6
Abstract Rationale This study is the first to measure and correlate sertraline concentrations in maternal blood, amniotic fluid and umbilical cord blood and... 
Psychiatry | Pregnancy | Therapeutic drug monitoring | Cord blood | Antidepressants | Amniotic fluid | Placental transfer | Depression | Pharmacokinetics | Sertraline | PRENATAL EXPOSURE | PSYCHIATRY | FETAL-GROWTH | PRETERM BIRTH | N-DEMETHYLATION | ANTIDEPRESSANT MEDICATIONS | CLINICAL NEUROLOGY | P-GLYCOPROTEIN | SEROTONIN REUPTAKE INHIBITORS | WOMEN | OUTCOMES | Prospective Studies | Sertraline - analysis | Humans | Sertraline - blood | Depressive Disorder - drug therapy | Serotonin Uptake Inhibitors - analysis | Pregnancy Complications - drug therapy | Placenta - metabolism | Amniotic Fluid - chemistry | Sertraline - administration & dosage | Serotonin Uptake Inhibitors - administration & dosage | Fetal Blood - chemistry | Adult | Female | Serotonin Uptake Inhibitors - blood | Drug Monitoring | Pregnancy - blood | Psychotherapy | Pregnant women | Health aspects | Patient monitoring equipment | Depression, Mental | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Selective uptake and biological consequences of environmentally relevant antidepressant pharmaceutical exposures on male fathead minnows
by Schultz, Melissa M and Painter, Meghan M and Bartell, Stephen E and Logue, Amanda and Furlong, Edward T and Werner, Stephen L and Schoenfuss, Heiko L
Aquatic Toxicology, ISSN 0166-445X, 2011, Volume 104, Issue 1, pp. 38 - 47
Antidepressant pharmaceuticals have been reported in wastewater effluent at the nanogram to low microgram-per-liter range, and include bupropion (BUP),... 
Fathead minnow | Histology | Behavior | Vitellogenin | Pharmaceuticals | CONTAMINANTS | METABOLITES | MEDICATIONS | SERTRALINE | FLUOXETINE | SEROTONIN REUPTAKE INHIBITORS | WASTE-WATER | MARINE & FRESHWATER BIOLOGY | GROWTH | FISH | TOXICOLOGY | GONADOTROPIN | Bupropion - metabolism | Fluoxetine - toxicity | Testis - metabolism | Male | Antidepressive Agents - metabolism | Testis - drug effects | Brain - metabolism | Cyclohexanols - metabolism | Bupropion - toxicity | Cyclohexanols - toxicity | Female | Sertraline - metabolism | Endocrine Disruptors - metabolism | Vitellogenins - metabolism | Antidepressive Agents - analysis | Endocrine Disruptors - analysis | Water Pollutants, Chemical - analysis | Cyprinidae - metabolism | Endocrine Disruptors - toxicity | Antidepressive Agents - toxicity | Brain - drug effects | Reproduction - drug effects | Venlafaxine Hydrochloride | Water Pollutants, Chemical - metabolism | Animals | Testis - pathology | Water Pollutants, Chemical - toxicity | Sertraline - toxicity | Fluoxetine - metabolism | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Cost-Effectiveness of Prolonged Exposure Therapy Versus Pharmacotherapy and Treatment Choice in Posttraumatic Stress Disorder (the Optimizing PTSD Treatment Trial): A Doubly Randomized Preference Trial
by Le, QA and Doctor, JN and Zoellner, LA and Feeny, NC
JOURNAL OF CLINICAL PSYCHIATRY, ISSN 0160-6689, 03/2014, Volume 75, Issue 3, pp. 222 - 230
Objective: Cost-effectiveness of treatment for posttraumatic stress disorder (PTSD) may depend on type of treatment (eg, pharmacotherapy vs psychotherapy) and... 
WILLINGNESS-TO-PAY | PRIMARY-CARE | EFFICACY | SERTRALINE | SAFETY | PSYCHIATRY | ANXIETY DISORDERS | ADJUSTED LIFE-YEAR | PSYCHOLOGY, CLINICAL | Health Services - economics | Sertraline - pharmacology | Humans | Middle Aged | Patient Preference - statistics & numerical data | Male | Treatment Outcome | Serotonin Uptake Inhibitors - economics | Implosive Therapy - economics | Health Services - utilization | Stress Disorders, Post-Traumatic - therapy | Young Adult | Sertraline - administration & dosage | Implosive Therapy - methods | Serotonin Uptake Inhibitors - administration & dosage | Sertraline - economics | Time Factors | Stress Disorders, Post-Traumatic - drug therapy | Cost-Benefit Analysis | Stress Disorders, Post-Traumatic - economics | Quality of Life | Adult | Female | Serotonin Uptake Inhibitors - pharmacology | Index Medicus | SSRIs | Americans | Survivors | Prolonged Exposure Therapy | Longitudinal Study | Reexperiencing | PTSD (DSM-IV) | Randomized Clinical Trial | Health Care Costs | Treatment Effectiveness | Arousal | Treatment Preference | Adults | Avoidance | Stressors
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Pretreatment metabotype as a predictor of response to sertraline or placebo in depressed outpatients: A proof of concept
by Kaddurah-Daouk, R and Boyle, S.H and Matson, W and Sharma, S and Matson, S and Zhu, H and Bogdanov, M.B and Churchill, E and Krishnan, R.R and Rush, A.J and Pickering, E and Delnomdedieu, M
Translational Psychiatry, ISSN 2158-3188, 07/2011, Volume 1, Issue 7, pp. e26 - e26
The purpose of this study was to determine whether the baseline metabolic profile (that is, metabotype) of a patient with major depressive disorder (MDD) would... 
Metabolomics | Sertraline | Major depressive disorder | Placebo | major depressive disorder | metabolomics | PSYCHIATRY | placebo | sertraline | Depressive Disorder, Major - blood | Serotonin Uptake Inhibitors - metabolism | Double-Blind Method | Depressive Disorder, Major - metabolism | Humans | Middle Aged | Serotonin Uptake Inhibitors - therapeutic use | Sertraline - blood | Male | Metabolomics - methods | Psychiatric Status Rating Scales | Outpatients | Metabolic Networks and Pathways | Sertraline - therapeutic use | Least-Squares Analysis | Adult | Female | Serotonin Uptake Inhibitors - blood | Chromatography, Liquid - methods | Depressive Disorder, Major - drug therapy | Sertraline - metabolism | Index Medicus | Original
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Sertraline effects on cerebrospinal fluid monoamines and species-typical socioemotional behavior of female cynomolgus monkeys
by Shively, Carol A and Register, Thomas C and Higley, J Dee and Willard, Stephanie L
Psychopharmacology, ISSN 0033-3158, 4/2014, Volume 231, Issue 7, pp. 1409 - 1416
Although widely prescribed, little is known about the effects of selective serotonin reuptake inhibitors (SSRIs) on social behavior and cerebrospinal fluid... 
SSRI | Neurosciences | Biomedicine | Nonhuman primates | CSF | Social and emotional behavior | Pharmacology/Toxicology | Females | Psychiatry | Sertraline | PSYCHIATRY | FLUOXETINE | PRIMATES | NEUROSCIENCES | NEUROCHEMISTRY | SOCIAL-BEHAVIOR | SEROTONIN REUPTAKE INHIBITORS | THERAPY | PHARMACOLOGY & PHARMACY | MACAQUES | STRESS | Hierarchy, Social | Serotonin Uptake Inhibitors - pharmacokinetics | Sertraline - pharmacology | Hydroxyindoleacetic Acid - cerebrospinal fluid | Macaca fascicularis | Hydroxyindoleacetic Acid - metabolism | Dose-Response Relationship, Drug | Animals | Sertraline - administration & dosage | Sertraline - pharmacokinetics | Serotonin Uptake Inhibitors - administration & dosage | Social Behavior | Biogenic Monoamines - cerebrospinal fluid | Female | Biogenic Monoamines - metabolism | Serotonin Uptake Inhibitors - pharmacology | Circadian Rhythm - drug effects | Complications and side effects | Physiological aspects | Dosage and administration | Genetic aspects | Research | Cerebrospinal fluid | Social behavior in animals | Primates | Behavioral biology | Drug therapy | Psychopharmacology | Index Medicus | females | social and emotional behavior | sertraline
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights